首页> 外文OA文献 >Determination of palladium, platinum and rhodium in used automobile catalysts and active pharmaceutical ingredients using high-resolution continuum source graphite furnace atomic absorption spectrometry and direct solid sample analysis
【2h】

Determination of palladium, platinum and rhodium in used automobile catalysts and active pharmaceutical ingredients using high-resolution continuum source graphite furnace atomic absorption spectrometry and direct solid sample analysis

机译:使用高分辨率连续谱源石墨炉原子吸收光谱法和直接固体样品分析法测定废旧汽车催化剂和活性药物成分中的钯,铂和铑

摘要

© 2014 Elsevier B.V. All rights reserved. This work investigates the potential of high-resolution continuum source graphite furnace atomic absorption spectrometry for the direct determination of Pd, Pt and Rh in two samples of very different nature. While analysis of active pharmaceutical ingredients is straightforward and it is feasible to minimize matrix effects, to the point that calibration can be carried out against aqueous standard solutions, the analysis of used automobile catalysts is more challenging requiring the addition of a chemical modifier (NH4F·HF) to help in releasing the analytes, a more vigorous temperature program and the use of a solid standard (CRM ERM®-EB504) for calibration. However, in both cases it was possible to obtain accurate results and precision values typically better than 10% RSD in a fast and simple way, while only two determinations are needed for the three analytes, since Pt and Rh can be simultaneously monitored in both types of samples. Overall, the methods proposed seem suited for the determination of these analytes in such types of samples, offering a greener and faster alternative that circumvents the traditional problems associated with sample digestion, requiring a small amount of sample only (0.05 mg per replicate for catalysts, and a few milligrams for the pharmaceuticals) and providing sufficient sensitivity to easily comply with regulations. The LODs achieved were 6.5 μg g- 1 (Pd), 8.3 μg g- 1 (Pt) and 9.3 μg g- 1 (Rh) for catalysts, which decreased to 0.08 μg g- 1 (Pd), 0.15 μg g- 1 (Pt) and 0.10 μg g- 1 (Rh) for pharmaceuticals.
机译:©2014 Elsevier B.V.保留所有权利。这项工作研究了高分辨率连续谱源石墨炉原子吸收光谱法直接测定性质迥异的两个样品中Pd,Pt和Rh的潜力。尽管活性药物成分的分析非常简单,并且可以最大程度地降低基体效应,但可以对标准水溶液进行校准,但对废旧汽车催化剂的分析则更具挑战性,需要添加化学改性剂(NH4F· HF)以帮助释放分析物,更严格的温度程序以及使用固体标准品(CRMERM®-EB504)进行校准。但是,在两种情况下,都可以快速,简单地获得准确的结果和精度值,通常优于10%RSD,而三种分析物只需进行两次测定,因为可以同时监测两种类型的Pt和Rh样本。总体而言,所提出的方法似乎适用于此类样品中这些分析物的测定,提供了一种绿色环保且速度更快的替代方法,可解决与样品消化相关的传统问题,仅需少量样品(催化剂每份重复量为0.05 mg,和几毫克的药品),并提供足够的敏感性以轻松遵守法规。催化剂的LOD为6.5μgg-1(Pd),8.3μgg-1(Pt)和9.3μgg-1(Rh),分别降至0.08μgg-1(Pd),0.15μgg-1 (Pt)和0.10μgg-1(Rh)用于药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号